During the onset of benign paroxysmal positional vertigo (BPPV), patients with motion sickness may experience more severe vestibular symptoms, which may affect the occurrence of residual dizziness (RD). OBJECTIVES: To study the correlation between RD after BPPV and motion sickness.

If the study finds a significant link, audiologists and vestibular clinicians should consider screening for motion sickness history before BPPV repositioning to better counsel patients on residual dizziness risk — but results must be reviewed before changing practice.

Identifying pre-existing motion sickness susceptibility as a predictor of residual dizziness after BPPV repositioning could help clinicians set more accurate patient expectations and guide post-treatment management.

1. 01Study investigates residual dizziness after BPPV (inner-ear crystal repositioning) treatment and its link to motion sickness history.